About the iPLEDGE^™ Program

If you’re thinking about starting treatment with ABSORICA, talk to your Dermatology Healthcare Professional about both the possible side effects of isotretinoin and the iPLEDGE Program.

The goal of the iPLEDGE Program is to prevent pregnancies in females taking isotretinoin and to prevent pregnant females from taking isotretinoin. This is because there is a very high chance of birth defects if an unborn baby’s mother takes isotretinoin. The iPLEDGE Program requires 2 forms of birth control for female patients who can get pregnant for at least 1 month before, during, and 1 month after stopping treatment and pregnancy tests before, during, and after treatment. Both male patients and female patients must enroll and follow the requirements of the iPLEDGE Program.

To get isotretinoin, all patients must:

• Sign the Patient Information/Informed Consent form(s). Your Dermatology Healthcare Professional will go over them with you. Be sure to ask any questions you may have.
• Keep appointments. Keep in mind that treatment usually lasts 4 to 5 months.
• Fulfill the iPLEDGE Program requirements. For details, talk to your doctor or visit the iPLEDGE Program website.

Both male and female patients only get isotretinoin for one month at a time. You must have an appointment with your Dermatology Healthcare Professional to get your prescription. At that time, be sure to schedule your next appointment. If you're a woman who can get pregnant, you'll also need to go in to get your monthly pregnancy test. For more detailed information, visit the iPLEDGE Program website.

This may be a lot to take in. Your healthcare team is there to answer any questions you may have — and lean on your family for support to help you stay on track. If you and your Dermatology Healthcare Professional decide ABSORICA is right for you, it’s very important to take your treatment as prescribed and to follow the requirements of the iPLEDGE Program — for your safety.